Skip to Main Content
 

Global Search Box

 
 
 
 

Files

File List


akron1186425531.pdf (6.49 MB)

ETD Abstract Container

Abstract Header

SIMVASTATIN INCORPORATED PERIVASCULAR POLYMERIC CONTROLLED DRUG DELIVERY SYSTEM FOR THE INHIBITION OF VASCULAR WALL INTIMAL HYPERPLASIA

Krishnan, Aadithya
http://rave.ohiolink.edu/etdc/view?acc_num=akron1186425531

Abstract Details

2007, Master of Science in Engineering, University of Akron, Biomedical Engineering.
Dialysis access graft failure is a major complication in providing care to patients on hemodialysis therapy. The failure rates have been reported as high as 80% at one year for this procedure. The major cause of failure is intimal hyperplasia. Intimal hyperplasia is an exaggeration of the normal vascular wall healing response to injury resulting from the migration and proliferation of medial smooth muscle cells. To mitigate this disease condition, we developed a perivascular polymeric controlled drug delivery device which we hypothesized when applied locally, would be effective in preventing intimal hyperplasia by enabling a sustained release of the therapeutic agent to the anastamotic site. This novel polymeric device, named PolyRing, is a composite system consisting of poly (DL-lactide-co-glycolide) microspheres embedded in a poly (ethylene glycol) hydrogel. The drug for the treatment of intimal hyperplasia is encapsulated within the poly (DL-lactide-co-glycolide) microspheres. The device is snapped into place around the vessel to deliver the drug. This work focuses on evaluating the feasibility of releasing the drug Simvastatin from the device to provide localized, site specific, sustained drug delivery for the prevention of intimal hyperplasia in vascular tissue. Simvastatin, obtained in a pro-drug form, when hydrolyzed to its active form, Simvastatin Acid, acts as a potent competitive inhibitor of the 3-Hydroxy-3-methylglutaryl coenzyme A reductase. The inhibition of this enzyme suppresses the mevalonate pathway and thereby prevents the proliferation of smooth muscle cells. As the focus is on controlled localized delivery, we hypothesize the need of using the active form as against the lactone form. Therefore, we fabricated Simvastatin and Simvastatin Acid loaded poly (DL-lactide-co-glycolide) microspheres using oil-water and water-oil-water techniques respectively. The oil-water emulsion resulted in smooth surfaced microspheres (determined by Scanning Electron Microscopy) with a particle size of approximately 50ìm (determined by dynamic light scattering), a yield range of 65-85 % and a drug loading efficiency of approximately 81%. The water-oil-water emulsion for simvastatin acid produced microparticles with a yield in the range of 60-70 % and a loading efficiency of approximately 7%. The Simvastatin Acid loaded microspheres had a smooth surface morphology with a particle size in the range of 2-25 microns. PolyRings were characterized by environmental scanning electron microscopy and revealed a uniform distribution of the drug-loaded microspheres in the poly (ethylene glycol) hydrogel matrix. The cell culture study to compare the efficacy of the two forms of the drug in inhibiting smooth muscle cell proliferation indicated that the inhibitory effect of Simvastatin Acid was significantly higher than that of Simvastatin. The release of Simvastatin Acid from the device lasted for about 70 days. Further, the Simvastatin Acid loaded device successfully inhibited the proliferation of smooth muscle cells in culture. Therefore, we conclude that the device, PolyRing, has been successfully modified for the controlled delivery of statins to inhibit intimal hyperplasia.
Stephanie Lopina (Advisor)
181 p.
Intimal Hyperplasia; Dialysis access; Perivascular Controlled Drug Delivery System; Statins; Inhibtion of Smooth Muscle Cell Proliferation; Hydrogels; Microspheres; Polyethylene glycol; PLGA

Recommended Citations

Citations

  • Krishnan, A. (2007). SIMVASTATIN INCORPORATED PERIVASCULAR POLYMERIC CONTROLLED DRUG DELIVERY SYSTEM FOR THE INHIBITION OF VASCULAR WALL INTIMAL HYPERPLASIA [Master's thesis, University of Akron]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=akron1186425531

    APA Style (7th edition)

  • Krishnan, Aadithya. SIMVASTATIN INCORPORATED PERIVASCULAR POLYMERIC CONTROLLED DRUG DELIVERY SYSTEM FOR THE INHIBITION OF VASCULAR WALL INTIMAL HYPERPLASIA. 2007. University of Akron, Master's thesis. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=akron1186425531.

    MLA Style (8th edition)

  • Krishnan, Aadithya. "SIMVASTATIN INCORPORATED PERIVASCULAR POLYMERIC CONTROLLED DRUG DELIVERY SYSTEM FOR THE INHIBITION OF VASCULAR WALL INTIMAL HYPERPLASIA." Master's thesis, University of Akron, 2007. http://rave.ohiolink.edu/etdc/view?acc_num=akron1186425531

    Chicago Manual of Style (17th edition)

akron1186425531
2,381
© 2007, all rights reserved.
This open access ETD is published by University of Akron and OhioLINK.